Tags:AnalyticsArtificial IntelligenceBioTechClinicDataDrugHealthLearnPersonal
Using ultra efficient AI to accelerate the treatment of rare diseases We?re a next-generation team of drug hunters, AI engineers and bioinformaticians, all working together to accelerate the discovery of new treatments for rare diseases. We work to leverage the power of AI so that, together, we can discover new treatments and move them towards the clinic within 24 months. We use AI to discover treatments because we believe in leveraging the quickest and most powerful way forward.
Location: United Kingdom, Cambridge
Member count: 11-50
Total raised: $68.056282M

Investors 6

Funding Rounds 3

DateSeriesAmountInvestorsDeal News
16.10.2019Series B$56.146428...--
26.07.2018Series A$10M--
04.10.2016Series A$1.909854MAmadeus Ca...-

Mentions in press and media 72

DateTitleDescriptionCategoryAuthorSource
20.10.2021UK startup...There are currently no approve...AI, biotec...Emma Betue...techcrunch...
12.08.2021Healx laun...Healx launches AI-powered indi...--cambridgen...
12.08.2021Healx laun...Healx launches AI-powered indi...--cambridgen...
30.06.2021Tech.eu Po...The Tech.eu Podcast is a show ...--tech.eu/ne...
23.06.2021Internatio...International Women in Enginee...--digit.fyi/...
23.06.2021Internatio...International Women in Enginee...--digit.fyi/...
28.04.2021Healx appo...Healx appoints ex-Dyson and GC...--cambridgen...
28.04.2021Healx appo...Healx appoints ex-Dyson and GC...--cambridgen...
09.04.2021Healx laun...Healx launches partnership wit...--cambridgen...
09.04.2021Healx laun...Healx launches partnership wit...--cambridgen...
Show more